Skip to main content
. 2024 Jun 28;24:779. doi: 10.1186/s12885-024-12531-z

Table 1.

Patient characteristics

Characteristic Number of Patients (%)
Sex
 Male 90 (84.9%)
 Female 16 (15.1%)
Age
 ≤ 60 years 39 (36.8%)
 > 60 years 67 (63.2%)
Smoking history
 No 48 (45.3%)
 Yes 58 (54.7%)
Alcohol history
 No 52 (49.1%)
 Yes 54 (50.9%)
Tumor location
 Upper 53 (50.0%)
 Middle + Distal 53 (50.0%)
GTV
 ≤ 48.4cm3 53 (50.0%)
 > 48.4cm3 53 (50.0%)
Clinical stage
 II 27 (25.5%)
 III-IVa 79 (74.5%)
Radiotherapy dose
 ≤ 41.4 Gy 94 (88.7%)
 > 41.4 Gy 12 (11.3%)
Chemotherapy regimen
 FP 17 (16.0%)
 TP 89 (84.0%)

GTV, gross tumor volume; PF cisplatin/fluorouracil; TP cisplatin/taxane